Many organizations begin with a focused oncology deployment — often lung.
Closed-loop patient management should not vary by diagnosis or facility.
Enterprise oncology expansion ensures consistent workflows across:
Without standardization:
Enterprise expansion eliminates variability and aligns performance across oncology programs.
Many health systems begin with lung incidental findings.
Imaging-driven findings extend beyond a single program.
Pancreatic cysts, liver lesions, complex GI findings, and structured screening follow-up require the same disciplined coordination.
Without standardized surveillance:
Enterprise expansion enables incidental findings workflows to be standardized across programs and facilities — ensuring every imaging-driven finding enters a closed-loop pathway.
This transforms incidental findings from a local program into enterprise imaging and structured follow-up infrastructure.
Closed-loop oncology becomes an enterprise standard — not a local program.
▶ View Oncology Expansion Executive Brief
Evaluate activation opportunities across cancer programs and facilities.